Trial Profile
a randomized clinical trial to study whether adefovir can improve the prognosis of HCC patients with HBV-DNA>=10000 copies/ml
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Adefovir
- Indications Hepatitis B; Liver cancer
- Focus Therapeutic Use
- 08 Jun 2016 Status changed from active, no longer recruiting to completed.
- 19 Aug 2011 New trial record